Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-10
1995-07-04
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514402, 5483011, A61K 31415, C07D491107
Patent
active
054300487
ABSTRACT:
Spiro- [4H- 1 -benzopyran-4,4'-5'H-imidazol]-5'-ones of the Formula 1: ##STR1## wherein R.sup.1 is H, R.sup.2 F, Cl, Br, CF.sub.3, CF.sub.3 O, CN, NO.sub.2, R.sup.2 SO.sub.2, R.sup.2 NHSO.sub.2, R.sup.2 O, R.sup.2 CO, R.sup.2 OCO, or R.sup.2 NHCO. R.sup.2 is a C.sub.1 -C.sub.10 branched or linear alkyl, a C.sub.3-8 cycloalkyl, phenyl, or benzyl. X can be S, O, or NH. Both enantiomers are included in this invention as well as salts and tautomeric forms of these compounds. The subject compounds are useful in the treatment of hypertension, alopecia, and erectile dysfunction.
REFERENCES:
patent: 4740517 (1988-08-01), Kurono et al.
patent: 4874869 (1989-10-01), Ueda et al.
Corneglio Donald L.
Morris Patricia L.
The Upjohn Company
LandOfFree
Spirocyclic benzopyran imidazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirocyclic benzopyran imidazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirocyclic benzopyran imidazolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-760391